Phathom Pharmaceuticals Presents New Data Evaluating First-in-Class Potassium-Competitive Acid Blocker (PCAB) Vonoprazan as Novel On-Demand Treatment in NERD at American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting
(10% Negative) SILVERBACK THERAPEUTICS, INC. (SBTX) Announces Delay in anaphylaxis Trials for review ARS Pharmaceuticals Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment